ALPS Advisors’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-43,803
| Closed | -$252K | – | 1027 |
|
|
2025
Q1 | $252K | Sell |
43,803
-4,352
| -9% | -$25K | ﹤0.01% | 947 |
|
|
2024
Q4 | $240K | Buy |
48,155
+2,619
| +6% | +$13.1K | ﹤0.01% | 958 |
|
|
2024
Q3 | $245K | Sell |
45,536
-790
| -2% | -$4.26K | ﹤0.01% | 970 |
|
|
2024
Q2 | $153K | Buy |
+46,326
| New | +$153K | ﹤0.01% | 958 |
|
|
2023
Q4 | – | Sell |
-43,250
| Closed | -$289K | – | 962 |
|
|
2023
Q3 | $289K | Buy |
43,250
+192
| +0.4% | +$1.28K | ﹤0.01% | 895 |
|
|
2023
Q2 | $361K | Buy |
43,058
+4,477
| +12% | +$37.6K | ﹤0.01% | 702 |
|
|
2023
Q1 | $383K | Sell |
38,581
-1,175
| -3% | -$11.7K | ﹤0.01% | 638 |
|
|
2022
Q4 | $277K | Buy |
39,756
+7,943
| +25% | +$55.3K | ﹤0.01% | 929 |
|
|
2022
Q3 | $170K | Sell |
31,813
-2,768
| -8% | -$14.8K | ﹤0.01% | 1014 |
|
|
2022
Q2 | $138K | Sell |
34,581
-25,125
| -42% | -$100K | ﹤0.01% | 1015 |
|
|
2022
Q1 | $265K | Sell |
59,706
-7,517
| -11% | -$33.4K | ﹤0.01% | 783 |
|
|
2021
Q4 | $269K | Sell |
67,223
-3,692
| -5% | -$14.8K | ﹤0.01% | 848 |
|
|
2021
Q3 | $623K | Sell |
70,915
-4,988
| -7% | -$43.8K | 0.01% | 473 |
|
|
2021
Q2 | $860K | Buy |
75,903
+5,676
| +8% | +$64.3K | 0.01% | 422 |
|
|
2021
Q1 | $834K | Buy |
70,227
+1,057
| +2% | +$12.6K | 0.01% | 421 |
|
|
2020
Q4 | $475K | Buy |
+69,170
| New | +$475K | 0.01% | 505 |
|